Happy 25th Anniversary, Xerimis!
On June 1, 2001, Xerimis Inc. officially opened its doors with the goal of providing superior clinical trial services in support of pharmaceutical innovation.
MHRA Regulatory Update
The United Kingdom’s competent authority MHRA (Medicines and Healthcare products Regulatory Agency) has announced it is planning significant amendments to the UK’s clinical trials legislation by 2026. These changes are aimed at fostering innovation while maintaining the highest standards of patient safety. Here is a summary of the key plans based on the MHRA’s proposals and ongoing consultations as of late 2023:
Xerimis Partners With Area Europe on State-of-the-Art Facility in the Netherlands
We’re thrilled to be working alongside Area Europe, a UK-based construction firm specializing in workplaces, on the design and fit-out of our environmentally sustainable facility in the Netherlands. The 45,000-square-foot site marks the new location for our next global depot, enabling us to increase operations in alignment with the growing needs of our clients.
EU Clinical Trials Regulation Is Here
The EU Clinical Trials Regulation (CTR) has been in the works since 2014, but now that it’s actually here, what are the basics you need to know?